Regarding the cognitive impairment, FOS supplementation to transgenic AD mice increased Glucagon-like peptide-1 (GLP-1), a protein that readily crosses the blood-brain barrier (BBB) and promotes satiety, pancreatic secretions of insulin and slowing of gastric emptying [61]. Here, INS is linked to Alzheimer disease.